Systemic Therapy for Estrogen Receptor–Positive, HER2-Negative Breast Cancer

This review covers the various treatments strategies for estrogen receptor positive, HER2 negative breast cancer. It concludes that emerging insights into the biology of these tumours has allowed for therapy to be highly tailored and individualised.

Source:

New England Journal of Medicine